Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000544374 | SCV000629776 | pathogenic | Li-Fraumeni syndrome | 2017-08-16 | criteria provided, single submitter | clinical testing | This sequence change deletes 1 nucleotide from exon 4 of the TP53 mRNA (c.112delC), causing a frameshift at codon 38. This creates a premature translational stop signal (p.Gln38Lysfs*6) and is expected to result in an absent or disrupted protein product. While this particular variant has not been reported in the literature as a germline variant, loss-of-function variants in TP53 are known to be pathogenic (PMID: 20522432). For these reasons, this variant has been classified as Pathogenic. |